Cytokine-induced cytokine production by conventional and innate lymphoid cells

Trends in Immunology

Volumn 33, Issue 12, 2012, Pages 598-606

  Guo, Liying ^a   Junttila, Ilkka S ^b,c   Paul, William E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

Cytokine; Effector; IL 1; ILC; Innate; STAT; T helper cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 7 RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; STAT PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

BASOPHIL; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOID CELL; MAST CELL; MEMORY T LYMPHOCYTE; MOUSEPOX; NATURAL KILLER T CELL; NEUTROPHIL; REVIEW; T LYMPHOCYTE; WILD TYPE;

BASOPHILS; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; LYMPHOCYTES; MAST CELLS; NEUTROPHILS;

EID: 84869865357     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.07.006     Document Type: Review

References (117)

1. Janeway C.A., Medzhitov R. Innate immune recognition. Ann. Rev. Immunol. 2002, 20:197-216.
2. Takeda K., et al. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
3. Tschopp J., et al. Intracellular pattern recognition receptors in the host response. Nature 2006, 442:39-44.
4. Sallusto F., et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
5. Sallusto F., et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
6. Seder R.A., Ahmed R. Similarities and differences in CD4(+) and CD8(+) effector and memory T cell generation. Nat. Immunol. 2003, 4:835-842.
7. Robinson D., et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997, 7:571-581.
8. Yoshimoto T., et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 1998, 161:3400-3407.
9. Yang J., et al. Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 1999, 29:548-555.
10. Thieu V.T., et al. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 2008, 29:679-690.
11. Zhu J., et al. Stat5 activation plays a critical role in Th2 differentiation. Immunity 2003, 19:739-748.
12. Yang X.O., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007, 282:9358-9363.
13. Guo L., et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13463-13468.
14. Sutton C., et al. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
15. Cho M.L., et al. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 2006, 176:5652-5661.
16. Schleimer R.P., et al. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J. Immunol. 2007, 179:1080-1087.
17. Luthi A.U., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
18. Zhang N., Bevan M.J. CD8(+) T cells: foot soldiers of the immune system. Immunity 2011, 35:161-168.
19. Hu J., et al. Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active Itk. Eur. J. Immunol. 2007, 37:2892-2899.
20. Carter L.L., Murphy K.M. Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J. Exp. Med. 1999, 189:1355-1360.
21. Kambayashi T., et al. Memory CD8+ T cells provide an early source of IFN-gamma. J. Immunol. 2003, 170:2399-2408.
22. Berg R.E., et al. Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur. J. Immunol. 2002, 32:2807-2816.
23. Berg R.E., et al. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 2003, 198:1583-1593.
24. Freeman C.M., et al. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J. Immunol. 2010, 184:6504-6513.
25. Wang Y., et al. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J. Immunol. 2009, 183:3324-3331.
26. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
27. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009, 31:15-23.
28. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011, 12:21-27.
29. Spits H., Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 2012, 30:647-675.
30. Biron C.A., et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189-220.
31. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 2006, 24:257-286.
32. Fehniger T.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 1999, 162:4511-4520.
33. Cooper M.A., et al. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells. Eur. J. Immunol. 2001, 31:792-801.
34. Lauwerys B.R., et al. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 1999, 11:822-830.
35. Tripp C.S., et al. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:3725-3729.
36. Carlyle J.R., et al. Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny. J. Immunol. 1998, 160:744-753.
37. Schmitt T.M., et al. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J. Exp. Med. 2004, 200:469-479.
38. Veinotte L.L., et al. Unique subset of natural killer cells develops from progenitors in lymph node. Blood 2008, 111:4201-4208.
39. Vosshenrich C.A.J., et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 2006, 7:1217-1224.
40. Kelly K.A., Scollay R. Seeding of neonatal lymph nodes by T cells and identification of a novel population of CD3-CD4+ cells. Eur. J. Immunol. 1992, 22:329-334.
41. Cherrier M., Eberl G. The development of LTi cells. Curr. Opin. Immunol. 2012, 24:178-183.
42. Eberl G., et al. An essential function for the nuclear receptor ROR gamma t in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 2004, 5:64-73.
43. Kurebayashi S., et al. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10132-10137.
44. Sun Z., et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000, 288:2369-2373.
45. Lee J.S., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:U144-U158.
46. Acosta-Rodriguez E.V., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
47. Annunziato F., et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
48. Sonnenberg G.F., et al. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011, 34:122-134.
49. Takatori H., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206:35-41.
50. Cupedo T., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC(+) CD127(+) natural killer-like cells. Nat. Immunol. 2009, 10:66-74.
51. Cella M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
52. Crellin N.K., et al. Human NKp44(+)IL-22(+) cells and LTi-like cells constitute a stable RORC(+) lineage distinct from conventional natural killer cells. J. Exp. Med. 2010, 207:281-290.
53. Luci C., et al. Influence of the transcription factor ROR gamma t on the development of NKp46(+) cell populations in gut and skin. Nat. Immunol. 2009, 10:75-82.
54. Sanos S.L., et al. ROR gamma t and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46(+) cells. Nat. Immunol. 2009, 10:83-91.
55. Satoh-Takayama N., et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3(-)NKp46(+) cell subsets from Id2-dependent precursors. J. Exp. Med. 2010, 207:273-280.
56. Satoh-Takayama N., et al. Microbial flora drives interleukin 22 production in intestinal NKp46(+) cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
57. Geremia A., et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 2011, 208:1127-1133.
58. Buonocore S., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.
59. Reynders A., et al. Identity, regulation and in vivo function of gut NKp46+RORgammat+ and NKp46+RORgammat- lymphoid cells. EMBO J. 2011, 30:2934-2947.
60. Adachi O., et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
61. Cella M., et al. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:10961-10966.
62. Fort M.M., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 15:985-995.
63. Neill D.R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
64. Moro K., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
65. Chang Y.J., et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 2011, 12:631-638.
66. Price A.E., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11489-11494.
67. Mjosberg J.M., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 2011, 12:1055-1062.
68. Monticelli L.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011, 12:1045-1054.
69. Ikutani M., et al. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J. Immunol. 2012, 188:703-713.
70. Bartemes K.R., et al. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 2012, 188:1503-1513.
71. Wong S.H., et al. Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 2012, 13:229-236.
72. Liang H.E., et al. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat. Immunol. 2012, 13:U58-U83.
73. Yang Q., et al. Cutting edge: natural helper cells derive from lymphoid progenitors. J. Immunol. 2011, 187:5505-5509.
74. Halim T.Y., et al. Lung natural helper cells are a critical source of th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012, 36:451-463.
75. Fallon P.G., et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 2006, 203:1105-1116.
76. Barlow J.L., et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 2012, 129:191-198.
77. Yasuda K., et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3451-3456.
78. Bendelac A., et al. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
79. Leite-De-Moraes M.C., et al. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J. Immunol. 1999, 163:5871-5876.
80. MacDonald H.R., Eberl G. Rapid death and regeneration of NKT cells in anti-CD3 epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998, 9:345-353.
81. Bendelac A., et al. The contribution of NKT cells, NK cells, and other gamma-chain-dependent non-T non-B cells to IL-12-mediated rejection of tumors. J. Immunol. 2003, 170:1197-1201.
82. Benedict C.A., et al. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 2008, 181:4452-4456.
83. Brenner M.B., et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 2011, 208:1163-1177.
84. Dustin M.L., et al. Activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J. Immunol. 2008, 180:2024-2028.
85. Herbelin A., et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 2009, 39:1046-1055.
86. Rachitskaya A.V., et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 2008, 180:5167-5171.
87. Coquet J.M., et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11287-11292.
88. Michel M.L., et al. Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19845-19850.
89. Doisne J.M., et al. Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J. Immunol. 2011, 186:662-666.
90. Doisne J.M., et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J. Immunol. 2009, 183:2142-2149.
91. Terashima A., et al. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 2008, 205:2727-2733.
92. Carding S.R., Egan P.J. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2002, 2:336-345.
93. Skeen M.J., Ziegler H.K. Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J. Immunol. 1995, 154:5832-5841.
94. Sutton C.E., et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
95. Shibata K., et al. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 2007, 178:4466-4472.
96. Jensen K.D., et al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 2008, 29:90-100.
97. Ribot J.C., et al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat. Immunol. 2009, 10:427-436.
98. Haas J.D., et al. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Eur. J. Immunol. 2009, 39:3488-3497.
99. Weinreich M.A., et al. T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells. Nat. Immunol. 2010, 11:709-716.
100. Min H.S., et al. MHC class II-restricted interaction between thymocytes plays an essential role in the production of innate CD8+ T cells. J. Immunol. 2011, 186:5749-5757.
101. Galli S.J., et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
102. Karasuyama H., et al. Nonredundant roles of basophils in immunity. Annu. Rev. Immunol. 2011, 29:45-69.
103. Kondo Y., et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 2008, 20:791-800.
104. Yoshimoto T., et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13962-13966.
105. Kroeger K.M., et al. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. J. Leukoc. Biol. 2009, 86:769-778.
106. Min B., Paul W.E. Basophils and type 2 immunity. Curr. Opin. Hematol. 2008, 15:59-63.
107. Ho L.H., et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J. Leukoc. Biol. 2007, 82:1481-1490.
108. Siracusa M.C., et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011, 477:229-233.
109. Silbermann K., et al. Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-kappaB and NFAT. J. Gen. Virol. 2008, 89:2788-2798.
110. Casolaro V., et al. Inhibition of NF-AT-dependent transcription by NF-kappa B: implications for differential gene expression in T helper cell subsets. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11623-11627.
111. Neumann M., et al. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 1995, 14:1991-2004.
112. Das J., et al. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2001, 2:45-50.
113. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 2006, 6:173-182.
114. Li L., et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 2010, 120:331-342.
115. Townsend M.J., et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004, 20:477-494.
116. Gordon S.M., et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012, 36:55-67.
117. Sullivan B.M., et al. Genetic analysis of basophil function in vivo. Nat. Immunol. 2011, 12:527-535.